Our model is also consistent with previous studies showing that deletion of FoxM1, a target gene of YAP1 transcriptional coactivator, inhibited the growth of p53 null thymic lymphoma and sarcoma cells 44. The gene discussed is TP53; the disease is thymus lymphoma.